Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Clinical and Translational Radiation Oncology|November 29, 2023
Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinomaArash Navran, Abrahim Al-Mamgani, Hester Elzinga, et al.
Plos One|November 9, 2018
Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint associationDavid M Vossen, Caroline V M Verhagen, Reidar Grénman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2017
Improved pharmacodynamic (PD) assessment of low dose PARP inhibitor PD activity for radiotherapy and chemotherapy combination trialsRosemarie de Haan, Dick Pluim, Baukelien van Triest, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 19, 2015
Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cellsCaroline V M Verhagen, Rosemarie de Haan, Floor Hageman, et al.
Cancers|April 3, 2019
Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive ChemoradiotherapyDavid M Vossen, Caroline V M Verhagen, Martijn van der Heijden, et al.
International Journal of Cancer|March 14, 2020
Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinomaPaul B M Essers, Martijn van der Heijden, David Vossen, et al.
Molecular Cancer Therapeutics|June 23, 2021
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical DevelopmentSonja J Gill, Paul W G Wijnhoven, Jacqueline H L Fok, et al.
Nature Communications|November 27, 2014
HSP90 regulates DNA repair via the interaction between XRCC1 and DNA polymerase βQingming Fang, Burcu Inanc, Sandy Schamus, et al.
Oncotarget|November 2, 2017
Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activityAmy J C Dohmen, Xiaohang Qiao, Anja Duursma, et al.
The Journal of Experimental Medicine|August 13, 2014
Tight regulation of ubiquitin-mediated DNA damage response by USP3 preserves the functional integrity of hematopoietic stem cellsCesare Lancini, Paul C M van den Berk, Joseph H A Vissers, et al.
Pageof 5